Moffitt researchers identify metastasis driver in BRAF inhibitor resistant melanoma

(H. Lee Moffitt Cancer Center& Research Institute) In a new article published in the Journal of Investigative Dermatology, Moffitt researchers identify erythropoietin-producing hepatocellular receptor A2 (EphA2) as a driver of metastasis and BRAF-MEK inhibitor resistance in melanoma.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news